SCHEMBL13367489

SCHEMBL13367489

CN(c1ccc(C(C)(C)C)cc1)c1ccccc1-c1cccc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.45
NR1I2 O75469 1/20 0.45
LMNA P02545 1/20 0.45
ADRA2A P08913 1/20 0.45
CYP2D6 P10635 1/20 0.45
ACHE P22303 1/20 0.45
SLC6A2 P23975 1/20 0.45
HTR2A P28223 1/20 0.45
SLC6A4 P31645 1/20 0.45
KCNH2 Q12809 1/20 0.45
KDR P35968 1/20 0.36
DHFR P00374 1/20 0.35
MEN1 O00255 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR1A P08908 2/20 0.35
HTR7 P34969 2/20 0.35
CCR4 P51679 1/20 0.34
NLRP3 Q96P20 1/20 0.34
HSD17B2 P37059 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13367357 0.88 SIGMAR1 (0.49) SIGMAR1NR1I2LMNAADRA2ACYP2D6
Hydrochloric Acid SCHEMBL29083708 0.86 SIGMAR1 (0.48) SIGMAR1NR1I2LMNAADRA2ACYP2D6
SCHEMBL13367483 0.83 SIGMAR1 (0.41) SIGMAR1CYP2D6DHFRHTR1AHTR7
SCHEMBL27380432 0.82 SLC6A9 (0.42) SIGMAR1DHFRHPGDPPARGPPARA
SCHEMBL13338562 0.82 SIGMAR1 (0.39) SIGMAR1NR1I2LMNAADRA2ACYP2D6
SCHEMBL13367365 0.79 MCL1 (0.41) SIGMAR1DHFRHTR1AHTR7
SCHEMBL25714922 0.78 TACR1 (0.42) MEN1KMT2ACYP19A1GPBAR1GPR84
SCHEMBL10053555 0.76 SIGMAR1 (0.47) SIGMAR1NR1I2LMNAADRA2ACYP2D6
SCHEMBL13367492 0.76 SIGMAR1 (0.40) SIGMAR1DHFRHTR1AHTR7
SCHEMBL15801361 0.75 SIGMAR1 (0.46) SIGMAR1NR1I2LMNAADRA2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 SIGMAR1 699/4885NR1I2 805/4885LMNA 4085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.